Lactobacillus salivarius WB21–containing tablets for the treatment of oral malodor: a double-blind, randomized, placebo-controlled crossover trial—reply to letter

Nao Suzuki; Masahiro Yoneda; Kazunari Tanabe; Akie Fujimoto; Kosaku Iha; Kei Seno; Kazuhiko Yamada; Tomoyuki Iwamoto; Yosuke Masuo; Takao Hirofuji

doi:10.1016/j.oooo.2014.06.014

Lactobacillus salivarius WB21–containing tablets for the treatment of oral malodor: a double-blind, randomized, placebo-controlled crossover trial—reply to letter

Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ◽

10.1016/j.oooo.2014.06.014 ◽

2014 ◽

Vol 118 (4) ◽

pp. 506 ◽

Cited By ~ 3

Author(s):

Nao Suzuki ◽

Masahiro Yoneda ◽

Kazunari Tanabe ◽

Akie Fujimoto ◽

Kosaku Iha ◽

...

Keyword(s):

Crossover Trial ◽

Oral Malodor ◽

Lactobacillus Salivarius ◽

Double Blind

Download Full-text

Lactobacillus salivarius WB21–containing tablets for the treatment of oral malodor: a double-blind, randomized, placebo-controlled crossover trial

Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ◽

10.1016/j.oooo.2013.12.400 ◽

2014 ◽

Vol 117 (4) ◽

pp. 462-470 ◽

Cited By ~ 31

Author(s):

Nao Suzuki ◽

Masahiro Yoneda ◽

Kazunari Tanabe ◽

Akie Fujimoto ◽

Kosaku Iha ◽

...

Keyword(s):

Crossover Trial ◽

Oral Malodor ◽

Lactobacillus Salivarius ◽

Double Blind

Download Full-text

1367: A Randomised Double Blind Crossover Trial of Melatonin to Treat Nocturia in Men with Benign Prostatic Hypertrophy

The Journal of Urology ◽

10.1016/s0022-5347(18)38592-6 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 360-360

Author(s):

Marcus J. Drake ◽

Jeremy G. Noble ◽

Ian Mills

Keyword(s):

Crossover Trial ◽

Benign Prostatic Hypertrophy ◽

Prostatic Hypertrophy ◽

Double Blind

Download Full-text

A Randomized, Double-Blind, Crossover Trial of Modafinil on Mood

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)70776-x ◽

2008 ◽

Vol 2008 ◽

pp. 198-199

Author(s):

J.C. Ballenger

Keyword(s):

Crossover Trial ◽

Double Blind

Download Full-text

ACCURATE PAIN REPORTING TRAINING DIMINISHES THE PLACEBO RESPONSE: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, CROSSOVER TRIAL

10.26226/morressier.598b05d9d462b80290b539fe ◽

2017 ◽

Author(s):

Roi Treister

Keyword(s):

Crossover Trial ◽

Placebo Response ◽

Double Blind ◽

Pain Reporting

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1070820.523755 ◽

2007 ◽

Author(s):

Andrew Wilcock

Keyword(s):

Advanced Cancer ◽

Crossover Trial ◽

Double Blind ◽

Effect Of Oxygen

Download Full-text

Faculty Opinions recommendation of Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1168153.630287 ◽

2009 ◽

Author(s):

Joel Katz ◽

Hance Clarke

Keyword(s):

Neuropathic Pain ◽

Crossover Trial ◽

Double Blind ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13445981.14821086 ◽

2012 ◽

Author(s):

Luca Persani

Keyword(s):

Crossover Trial ◽

Metabolic Effects ◽

Double Blind

Download Full-text

Faculty Opinions recommendation of Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13911956.15365056 ◽

2012 ◽

Author(s):

Chim Lang

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Ursodeoxycholic Acid ◽

Crossover Trial ◽

Double Blind

Download Full-text

Faculty Opinions recommendation of Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2567956.2306057 ◽

2010 ◽

Author(s):

John Louis Ratz

Keyword(s):

Hidradenitis Suppurativa ◽

Crossover Trial ◽

Infliximab Therapy ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717976484.793471199 ◽

2013 ◽

Author(s):

R Taylor Segraves

Keyword(s):

Crossover Trial ◽

Premenopausal Women ◽

Mu Opioid Receptor ◽

Double Blind ◽

Mu Opioid ◽

Double Blind Placebo ◽

High Affinity ◽

Arousal Disorder ◽

Sexual Arousal Disorder ◽

Female Sexual Arousal Disorder

Download Full-text